Barclays Portfolio holdings
Barclays is a British universal bank whose roots go back to 1690, when the Quakers John Freame and Thomas Gould started a goldsmith banking business in London. The Barclays name came into the business in 1736, when James Barclay, son-in-law of founder John Freame, became a partner. Barclays launched the UK's first credit card, Barclaycard, in 1966, and in 1967 put the world's first cash machine in a branch in Enfield. In 2008 Barclays bought the North American operations of Lehman Brothers, and in 2009 it sold its Barclays Global Investors unit, home of the iShares ETFs, to BlackRock. It runs five divisions: UK consumer banking, UK corporate banking, private banking and wealth management, an investment bank and a US consumer bank.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$17.5B |
| 2 |
NVIDIA
NVDA
|
+$2.7B |
| 3 |
Intel
INTC
|
+$1.98B |
| 4 |
Broadcom
AVGO
|
+$1.46B |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$1.11B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$35.8B |
| 2 |
Apple
AAPL
|
+$1.83B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$913M |
| 4 |
Microsoft
MSFT
|
+$856M |
| 5 |
Bank of America
BAC
|
+$792M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 49.47% |
| 2 | Technology | 19.84% |
| 3 | Consumer Discretionary | 7.61% |
| 4 | Financials | 5.61% |
| 5 | Communication Services | 3.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4551
PEDEVCO
PED
$198M
| $40.5K | ﹤0.01% |
3,113
+2,518
| +423% | +$32K |
2026 Q2
1 quarter
|
|
4552
Omega Flex
OFLX
$241M
| $40.5K | ﹤0.01% |
1,594
-478
| -23% | -$13.5K |
2019 Q1
30 quarters
|
|
4553
Definitive Healthcare
DH
$123M
| $40.4K | ﹤0.01% |
44,670
-279,000
| -86% | -$229K |
2022 Q1
18 quarters
|
|
4554
Lakefront Biotherapeutics American Depositary Shares
LKFT
$2.2B
| $40.1K | ﹤0.01% |
1,353
+1,234
| +1,037% | +$35.4K |
2024 Q3
8 quarters
|
|
4555
Biglari Holdings Class A
BH.A
$1B
| $39.9K | ﹤0.01% |
23
+7
| +44% | +$13.3K |
2026 Q2
1 quarter
|
|
4556
Comtech Telecommunications
CMTL
$34.1M
| $39.9K | ﹤0.01% |
29,106
+2
| +0% | +$3 |
2016 Q2
41 quarters
|
|
4557
MediciNova
MNOV
$71.9M
| $39.8K | ﹤0.01% |
23,735
-19,071
| -45% | -$31.4K |
2016 Q3
40 quarters
|
|
4558
EVI Industries
EVI
$270M
| $39.7K | ﹤0.01% |
2,069
+1,185
| +134% | +$18.7K |
2022 Q4
15 quarters
|
|
4559
Humacyte
HUMA
$125M
| $39.3K | ﹤0.01% |
76,001
+36,321
| +92% | +$23.2K |
2022 Q1
18 quarters
|
|
|
GPMT
4560
Granite Point Mortgage Trust
GPMT
$16.1M
| $38.9K | ﹤0.01% |
4,520
-45
| -1% | -$527 |
2017 Q3
36 quarters
|
|
4561
Vanguard FTSE All-World ex-US ETF
VEU
$65.1B
| $38.7K | ﹤0.01% |
467
| – | – |
2022 Q4
15 quarters
|
|
4562
Mastech Digital
MHH
$75.9M
| $38.6K | ﹤0.01% |
5,520
-25
| -0.5% | -$189 |
2020 Q2
25 quarters
|
|
4563
Mobia Medical
MOBI
$373M
| $38.3K | ﹤0.01% |
4,048
+3,152
| +352% | +$35.5K |
2026 Q2
1 quarter
|
|
4564
Innovator US Equity Buffer ETF May
BMAY
$176M
| $38K | ﹤0.01% |
+785
| New | +$37.8K |
2026 Q3
0 quarters
|
|
4565
AllianzIM U.S. Equity Buffer10 Aug ETF
AUGT
$34.5M
| $38K | ﹤0.01% |
970
| – | – |
2025 Q1
6 quarters
|
|
4566
SBC Medical Group
SBC
$518M
| $38K | ﹤0.01% |
7,683
+3,984
| +108% | +$14.9K |
2025 Q2
5 quarters
|
|
4567
BBH Select Mid Cap ETF
BBHM
$425M
| $37.9K | ﹤0.01% |
3,334
+1,277
| +62% | +$15.1K |
2026 Q2
1 quarter
|
|
4568
Immunic
IMUX
$106M
| $37.4K | ﹤0.01% |
4,025
+3,531
| +715% | +$48.6K |
2024 Q4
7 quarters
|
|
4569
Bluerock Homes Trust
BHM
$29.8M
| $37.1K | ﹤0.01% |
4,658
-13
| -0.3% | -$111 |
2022 Q4
15 quarters
|
|
4570
Envela
ELA
$280M
| $37K | ﹤0.01% |
3,066
+1,641
| +115% | +$28.3K |
2023 Q2
13 quarters
|
|
4571
Autolus Therapeutics
AUTL
$341M
| $36.8K | ﹤0.01% |
18,953
+7,014
| +59% | +$13.4K |
2026 Q1
2 quarters
|
|
4572
DELISTED
STRATUS PPTYS INC
STRS
| $36.8K | ﹤0.01% |
1,968
+1,858
| +1,689% | +$40.8K |
2022 Q2
17 quarters
|
|
4573
DMC Global
BOOM
$144M
| $36.5K | ﹤0.01% |
6,539
-5,167
| -44% | -$33.9K |
2017 Q1
38 quarters
|
|
4574
Suja Life Inc
SUJA
$235M
| $36.4K | ﹤0.01% |
+3,753
| New | +$33.8K |
2026 Q3
0 quarters
|
|
4575
UNIFI
UFI
$108M
| $36.3K | ﹤0.01% |
5,556
+1,606
| +41% | +$10.7K |
2016 Q2
41 quarters
|
|
Similar funds
Barclays's Q3 2026 Portfolio in Review
As of Q3 2026, Barclays held 5,855 positions worth $500B, down 4% from $521B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Barclays withdrew a net $19B in Q3 2026, closing 474 positions and reducing 1,494 holdings. Its most notable exit was ExxonMobil, an estimated $761M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 49% of assets, down from 55% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Barclays opened a new position in iShares Broad USD High Yield Corporate Bond ETF worth $199M.
- Barclays's largest Q3 2026 buy was iShares Broad USD High Yield Corporate Bond ETF: 5,582,517 shares worth $199M.
- Barclays added most to Tesla in Q3 2026, an estimated $17.5B increase.
- Barclays's biggest Q3 2026 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $35.8B.
- Barclays fully exited ExxonMobil in Q3 2026, selling an estimated $761M.
- Barclays's ten largest holdings make up 40% of its $500B portfolio in Q3 2026.
- Barclays opened 525 new positions and closed 474 in Q3 2026.
- Barclays's portfolio value fell 4% quarter-over-quarter to $500B.
Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.